Cargando…
The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery
SARS-CoV-2 is the pathogen responsible for the COVID-19 pandemic. The SARS-CoV-2 papain-like cysteine protease (PLpro) has been implicated in playing important roles in virus maturation, dysregulation of host inflammation, and antiviral immune responses. The multiple functions of PLpro render it a p...
Autores principales: | Fu, Ziyang, Huang, Bin, Tang, Jinle, Liu, Shuyan, Liu, Ming, Ye, Yuxin, Liu, Zhihong, Xiong, Yuxian, Zhu, Wenning, Cao, Dan, Li, Jihui, Niu, Xiaogang, Zhou, Huan, Zhao, Yong Juan, Zhang, Guoliang, Huang, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817691/ https://www.ncbi.nlm.nih.gov/pubmed/33473130 http://dx.doi.org/10.1038/s41467-020-20718-8 |
Ejemplares similares
-
Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow
por: Parmar, Paritosh, et al.
Publicado: (2021) -
Identifying structural–functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation
por: Rao, Priyashi, et al.
Publicado: (2021) -
In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542
por: Cho, Hyunki, et al.
Publicado: (2023) -
GrlR, a negative regulator in enteropathogenic E. coli, also represses the expression of LEE virulence genes independently of its interaction with its cognate partner GrlA
por: Lara-Ochoa, Cristina, et al.
Publicado: (2023) -
Fragments and hot spots in drug discovery
por: Vajda, Sandor, et al.
Publicado: (2015)